Activation	O
of	O
ephrinB	O
-	O
EphB	O
receptor	O
signalling	O
in	O
rat	B:C1882864
spinal	I:C1882864
cord	I:C1882864
contributes	O
to	O
maintenance	O
of	O
diabetic	O
neuropathic	O
pain	I:C3714625
.	O

Activation	O
of	O
ephrinB	O
-	O
EphB	O
receptor	O
signalling	O
in	O
rat	O
spinal	I:C1882864
cord	I:C1882864
contributes	O
to	O
maintenance	O
of	O
diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
.	O

Activation	O
of	O
ephrinB	O
-	O
EphB	O
receptor	O
signalling	O
in	O
rat	O
spinal	I:C1882864
cord	I:C1882864
contributes	O
to	O
maintenance	O
of	O
diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
.	O

Diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
(	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
)	O
is	O
severe	O
and	O
intractable	O
in	O
clinic	O
.	O

Diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
(	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
)	O
is	O
severe	O
and	O
intractable	O
in	O
clinic	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
(	O
Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
)	O
is	O
severe	O
and	O
intractable	O
in	O
clinic	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
(	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
)	O
is	O
severe	O
and	O
intractable	O
in	O
clinic	B:C0442592
.	O

The	O
specific	O
cellular	B:C0007613
and	O
molecular	O
mechanisms	O
underlying	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
remain	O
elusive	O
and	O
its	O
treatment	O
are	O
limited	O
.	O

The	O
specific	O
cellular	O
and	O
molecular	B:C1148560
mechanisms	O
underlying	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
remain	O
elusive	O
and	O
its	O
treatment	O
are	O
limited	O
.	O

The	O
specific	O
cellular	O
and	O
molecular	O
mechanisms	O
underlying	O
Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
remain	O
elusive	O
and	O
its	O
treatment	O
are	O
limited	O
.	O

We	O
investigated	O
roles	O
of	O
EphB1	B:C0907648
receptor	I:C0907648
in	O
the	O
development	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

We	O
investigated	O
roles	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
development	O
of	O
Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
.	O

Diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	O
(	O
streptozotocin	O
)	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	O
(	O
streptozotocin	O
)	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	B:C0034715
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	O
(	O
streptozotocin	O
)	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	B:C0038432
(	O
streptozotocin	O
)	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	O
(	O
streptozotocin	B:C0038432
)	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
by	O
a	O
single	O
i.p.	O
streptozotocin	O
(	O
streptozotocin	O
)	O
or	O
alloxan	B:C0002151
.	O

Western	B:C0949466
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	B:C0021044
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	B:C1171362
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	B:C0907648
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	B:C0027836
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	B:C0079189
cytokines	I:C0079189
in	O
the	O
spinal	O
cord	I:C0037925
.	O

Western	O
blot	I:C0949466
analysis	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
analyse	O
expression	O
of	O
EphB1	O
receptor	I:C0907648
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	O
cells	I:C0027836
and	O
the	O
pro-inflammatory	O
cytokines	I:C0079189
in	O
the	O
spinal	B:C0037925
cord	I:C0037925
.	O

Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	O
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	I:C0332467
of	O
the	O
hind	O
paw	O
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	B:C2936719
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	I:C0332467
of	O
the	O
hind	O
paw	O
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	O
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	B:C0016504
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	I:C0332467
of	O
the	O
hind	O
paw	O
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	O
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	B:C0332467
indentation	I:C0332467
of	O
the	O
hind	O
paw	O
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	O
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	I:C0332467
of	O
the	O
hind	B:C2983612
paw	O
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
manifested	O
as	O
mechanical	O
allodynia	I:C2936719
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	O
withdrawal	O
in	O
response	O
to	O
mechanical	O
indentation	I:C0332467
of	O
the	O
hind	O
paw	B:C0687080
by	O
an	O
electro	O
von	O
Frey	O
filament	O
.	O

Diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
and	O
high	O
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	O
that	O
received	O
i.p.	O
streptozotocin	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
and	O
high	O
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	O
that	O
received	O
i.p.	O
streptozotocin	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
and	O
high	B:C2919432
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	O
that	O
received	O
i.p.	O
streptozotocin	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
and	O
high	O
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	B:C0003062
that	O
received	O
i.p.	O
streptozotocin	O
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
and	O
high	O
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	O
that	O
received	O
i.p.	O
streptozotocin	B:C0038432
or	O
alloxan	O
.	O

Diabetic	O
neuropathic	O
pain	I:C3714625
and	O
high	O
blood	I:C2919432
glucose	I:C2919432
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	O
that	O
received	O
i.p.	O
streptozotocin	O
or	O
alloxan	B:C0002151
.	O

Phosphorylation	B:C0031715
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	B:C0907648
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	B:C0004112
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	B:C0206116
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	B:C1456820
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	B:C0021753
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	B:C0037925
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	B:C0034721
with	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

Phosphorylation	O
of	O
EphB1	O
,	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
,	O
and	O
level	O
of	O
tumour	O
necrosis	I:C1456820
factor	I:C1456820
(	O
TNF	I:C1456820
)	I:C1456820
-α	I:C1456820
and	O
interleukin	O
(	I:C0021753
IL	I:C0021753
)	I:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
spinal	O
cord	I:C0037925
were	O
significantly	O
increased	O
in	O
rats	O
with	O
Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
.	O

Spinal	B:C0521329
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	B:C0907648
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	B:C0038432
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	B:C1533685
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	B:C2936719
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	B:C0004112
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	B:C0206116
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	B:C1456820
and	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
late	O
phase	O
after	O
streptozotocin	O
injection	O
significantly	O
suppressed	O
the	O
established	O
mechanical	O
allodynia	I:C2936719
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	O
and	O
microglial	O
cells	I:C0206116
and	O
activity	O
of	O
TNF-α	O
and	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

However	O
,	O
spinal	B:C0521329
treatment	O
of	O
EphB1	O
-	O
Fc	O
in	O
the	O
early	O
phase	O
after	O
streptozotocin	O
injection	O
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

However	O
,	O
spinal	O
treatment	O
of	O
EphB1	B:C0907648
-	O
Fc	O
in	O
the	O
early	O
phase	O
after	O
streptozotocin	O
injection	O
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

However	O
,	O
spinal	O
treatment	O
of	O
EphB1	O
-	O
Fc	B:C0034805
in	O
the	O
early	O
phase	O
after	O
streptozotocin	O
injection	O
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

However	O
,	O
spinal	O
treatment	O
of	O
EphB1	O
-	O
Fc	O
in	O
the	O
early	O
phase	O
after	O
streptozotocin	B:C0038432
injection	O
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

However	O
,	O
spinal	O
treatment	O
of	O
EphB1	O
-	O
Fc	O
in	O
the	O
early	O
phase	O
after	O
streptozotocin	O
injection	B:C1533685
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	O
neuropathic	I:C3714625
pain	I:C3714625
.	O

However	O
,	O
spinal	O
treatment	O
of	O
EphB1	O
-	O
Fc	O
in	O
the	O
early	O
phase	O
after	O
streptozotocin	O
injection	O
did	O
not	O
prevent	O
the	O
induction	O
of	O
Diabetic	B:C3714625
neuropathic	I:C3714625
pain	I:C3714625
.	O

EphB1	B:C0907648
receptor	I:C0907648
activation	O
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	O
of	O
diabetic	O
pain	O
.	O

EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
spinal	B:C0037925
cord	I:C0037925
is	O
critical	O
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	O
of	O
diabetic	O
pain	O
.	O

EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	O
of	O
diabetic	B:C0241863
pain	O
.	O

EphB1	O
receptor	I:C0907648
activation	O
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	O
of	O
diabetic	O
pain	B:C0030193
.	O

EphB1	B:C0907648
receptor	I:C0907648
may	O
be	O
a	O
potential	O
target	O
for	O
relieving	O
the	O
established	O
diabetic	O
pain	O
.	O

EphB1	O
receptor	I:C0907648
may	O
be	O
a	O
potential	O
target	O
for	O
relieving	B:C0002766
the	O
established	O
diabetic	O
pain	O
.	O

EphB1	O
receptor	I:C0907648
may	O
be	O
a	O
potential	O
target	O
for	O
relieving	O
the	O
established	O
diabetic	B:C0241863
pain	O
.	O

EphB1	O
receptor	I:C0907648
may	O
be	O
a	O
potential	O
target	O
for	O
relieving	O
the	O
established	O
diabetic	O
pain	B:C0030193
.	O

Activation	O
of	O
EphB1	B:C0907648
receptor	I:C0907648
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	O
neuropathic	O
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	O
pain	O
induction	O
.	O

Activation	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
spinal	B:C0037925
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	O
neuropathic	O
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	O
pain	O
induction	O
.	O

Activation	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	O
pain	O
induction	O
.	O

Activation	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	O
pain	O
induction	O
.	O

Activation	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	O
neuropathic	O
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	B:C0241863
pain	O
induction	O
.	O

Activation	O
of	O
EphB1	O
receptor	I:C0907648
in	O
the	O
spinal	O
cord	I:C0037925
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	O
neuropathic	O
pain	I:C3714625
,	O
but	O
not	O
to	O
diabetic	O
pain	B:C0030193
induction	O
.	O

Spinal	B:C0521329
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
suppresses	O
ongoing	O
diabetic	O
neuropathic	O
pain	I:C3714625
.	O

Spinal	O
blocking	O
EphB1	B:C0907648
receptor	I:C0907648
activation	O
suppresses	O
ongoing	O
diabetic	O
neuropathic	O
pain	I:C3714625
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
suppresses	O
ongoing	O
diabetic	B:C0241863
neuropathic	O
pain	I:C3714625
.	O

Spinal	O
blocking	O
EphB1	O
receptor	I:C0907648
activation	O
suppresses	O
ongoing	O
diabetic	O
neuropathic	B:C3714625
pain	I:C3714625
.	O

